Asima Health

📍 Kitchener, Canada🗓 Founded 2023👥 6 employees💰 Last funded Aug 2025
Asima Health is a molecular diagnostics company building a fundamentally simpler foundation for frequent cancer monitoring. Our platform, Asima™ Rev, analyzes structural changes in cell-free DNA — eliminating complex, multi-step gene sequencing workflows and enabling faster, more scalable testing. We offer: • Multi-cancer capability from a single blood draw • High accuracy, as early as stage I • AI-enabled cancer staging insights • Rapid turnaround times • Simple lab-on-a-chip technology deployable in local labs Were launching with colorectal and lung cancer recurrence monitoring, with expansion planned across broader pan-cancer applications. Our mission is to make cancer monitoring more accessible, affordable, and practical for real-world patient care.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded
Investor geography2 countries
Singapore
1
United States
1
Frequently asked questions
Who invested in Asima Health?
Asima Health has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Asima Health last raise funding?
The most recent investment in Asima Health recorded on gritt.io was in August 2025.
When was Asima Health founded?
Asima Health was founded in 2023.
What industry is Asima Health in?
Asima Health operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Asima Health based?
Asima Health is headquartered in Kitchener, Canada.